Date published: 2026-6-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

Drebrin Inhibitors

The Drebrin Inhibitors represent a diverse group of chemicals that target specific cellular pathways critical for Drebrin's activation and function. Blebbistatin, for instance, inhibits Drebrin indirectly by disrupting actin dynamics through non-muscle myosin II inhibition. This disruption hinders Drebrin's ability to interact with actin filaments, impacting its cellular functions. Moreover, compounds like CK666 and CK869 inhibit Drebrin by targeting the Arp2/3 complex, pivotal for actin filament branching. By disrupting this complex, these inhibitors interfere with the actin cytoskeleton, influencing Drebrin-mediated cellular processes. Cytochalasin D and Latrunculin A, both actin-perturbing agents, directly inhibit Drebrin by disrupting actin polymerization, affecting the cytoskeletal framework essential for Drebrin's function. Jasplakinolide and Miuraenamide exert their inhibitory effects by stabilizing and interacting with actin filaments, respectively, hindering dynamic interactions with Drebrin. These inhibitors disrupt the finely tuned actin dynamics crucial for Drebrin's regulatory functions. Understanding the detailed interactions of these inhibitors with specific pathways and molecules provides valuable insights into the complex regulatory networks governing Drebrin. The chemical class of Drebrin Inhibitors serves as a vital resource for experimental investigations, offering a nuanced understanding of Drebrin's role in cellular processes. The diverse mechanisms employed by these inhibitors underscore the intricacies of Drebrin regulation, presenting a rich landscape for scientific exploration.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(±)-Blebbistatin

674289-55-5sc-203532B
sc-203532
sc-203532A
sc-203532C
sc-203532D
5 mg
10 mg
25 mg
50 mg
100 mg
$183.00
$313.00
$464.00
$942.00
$1723.00
7
(1)

Blebbistatin inhibits Drebrin indirectly by disrupting actin dynamics. It specifically targets non-muscle myosin II, preventing its interaction with actin filaments and influencing the cytoskeletal organization that Drebrin relies on for cellular functions.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Latrunculin A inhibits Drebrin by disrupting actin polymerization. It sequesters monomeric actin, preventing its incorporation into growing actin filaments. This disruption of actin dynamics impacts Drebrin's ability to interact with actin and modulate cellular processes.

CK 666

442633-00-3sc-361151
sc-361151A
10 mg
50 mg
$321.00
$1040.00
5
(0)

CK666 inhibits Drebrin indirectly by targeting the Arp2/3 complex, crucial for actin filament branching. By inhibiting Arp2/3, CK666 disrupts the actin cytoskeleton, affecting Drebrin's functional interactions with actin and downstream cellular processes.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Cytochalasin D inhibits Drebrin by disrupting actin polymerization. It binds to the growing ends of actin filaments, preventing further elongation. This interference with actin dynamics influences Drebrin's ability to regulate actin-dependent cellular functions.

SMIFH2

340316-62-3sc-507273
5 mg
$140.00
(0)

SMIFH2 inhibits Drebrin indirectly by disrupting formin-mediated actin polymerization. It specifically targets formin proteins, crucial for actin nucleation and elongation. By inhibiting formin, SMIFH2 impacts the actin cytoskeleton, affecting Drebrin-mediated cellular processes.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$184.00
$305.00
59
(1)

Jasplakinolide inhibits Drebrin by stabilizing actin filaments. It promotes actin polymerization and stabilizes F-actin structures, preventing dynamic interactions with Drebrin. This stabilization interferes with Drebrin's ability to modulate cellular functions dependent on actin dynamics.

CK-869

388592-44-7sc-507274
5 mg
$163.00
(0)

CK869 inhibits Drebrin indirectly by targeting the Arp2/3 complex. Similar to CK666, CK869 disrupts actin filament branching, affecting the actin cytoskeleton and Drebrin-mediated cellular processes by inhibiting the essential Arp2/3 complex involved in actin dynamics.

Latrunculin B

76343-94-7sc-203318
1 mg
$240.00
29
(1)

Latrunculin B inhibits Drebrin by disrupting actin polymerization, similar to Latrunculin A. It sequesters monomeric actin, preventing its incorporation into growing actin filaments. This interference with actin dynamics impacts Drebrin's ability to regulate actin-dependent cellular functions.

Cytochalasin B

14930-96-2sc-3519
5 mg
$199.00
19
(1)

Cytochalasin B inhibits Drebrin by disrupting actin polymerization, similar to Cytochalasin D. It binds to the growing ends of actin filaments, preventing further elongation. This interference with actin dynamics impacts Drebrin's ability to regulate actin-dependent cellular functions.